| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 2464-2469, Copyright © 1995 by Endocrine Society
ARTICLES |
G Perriello, P Misericordia, E Volpi, S Pampanelli, F Santeusanio, P Brunetti and GB Bolli
Dipartimento di Medicina Interna e Scienze Endocrine e Metaboliche, University of Perugia.
Inasmuch as previous studies have obtained conflicting results on the contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus (NIDDM), we studied 10 nonobese and 10 obese NIDDM patients with the isoglycemic-(approximately 10 mmol/L)- hyperinsulinemic clamp (two insulin infusions of 4 and 40 mU/m-2 min- 1), combined with [3-3H]glucose infusion and indirect calorimetry. As compared with nonobese patients, obese NIDDM patients had higher baseline peripheral and estimated portal plasma insulin concentrations (113 +/- 18 vs. 46 +/- 3 pmol/L and 288 +/- 53 vs. 98 +/- 6 pmol/L, respectively; P < 0.05) and less suppressed endogenous insulin production during clamp. Hepatic glucose production was greater in obese than in nonobese patients (basal, 16 +/- 1.1 vs. 12 +/- 0.5 mumol/kg-1 fat-free mass (FFM) min-1; clamp, 5.7 +/- 0.5 vs. 2.8 +/- 0.2 mumol/kg-1 FFM min-1, P < 0.05). Glucose utilization increased to a lesser extent in obese than in nonobese patients (49 +/- 5 vs. 73 +/- 7 mumol/kg-1 FFM min-1, P < 0.05) during clamp because of a lower increase in nonoxidative glucose metabolism (30 +/- 5 vs. 50 +/- 7 mumol/kg-1 FFM min-1, P < 0.05). Plasma free fatty acid concentrations and rates of lipid oxidation were greater in obese (P < 0.05) patients and correlated with hepatic glucose production (r = 0.79 and 0.50, P < 0.05). In conclusion, obesity exaggerates hepatic as well as extra- hepatic insulin resistance in NIDDM. The impaired inhibition of pancreatic beta-cell function by exogenous insulin contributes to exaggerated hyperinsulinemia in obese NIDDM.
This article has been cited by other articles:
![]() |
E. Volpi, S. A. Lieberman, D. M. Ferrer, C. R. Gilkison, B. B. Rasmussen, M. Nagamani, and R. J. Urban The Relationships Between Testosterone, Body Composition, and Insulin Resistance: A lesson from a case of extreme hyperandrogenism Diabetes Care, February 1, 2005; 28(2): 429 - 432. [Full Text] [PDF] |
||||
![]() |
E. Cho, J. E. Manson, M. J. Stampfer, C. G. Solomon, G. A. Colditz, F. E. Speizer, W. C. Willett, and F. B. Hu A Prospective Study of Obesity and Risk of Coronary Heart Disease Among Diabetic Women Diabetes Care, July 1, 2002; 25(7): 1142 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.B. CHAN, J.C.N. CHAN, C.C. CHOW, V.T.F. YEUNG, W.Y. SO, J.K.Y. LI, G.T.C. KO, R.C.W. MA, and C.S. COCKRAM Glycaemic control in type 2 diabetes: the impact of body weight, {beta}-cell function and patient education QJM, March 1, 2000; 93(3): 183 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Arciero, M. D. Vukovich, J. O. Holloszy, S. B. Racette, and W. M. Kohrt Comparison of short-term diet and exercise on insulin action in individuals with abnormal glucose tolerance J Appl Physiol, June 1, 1999; 86(6): 1930 - 1935. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |